TCS PrP Inhibitor 13

Research use only, not for human use.

TCS PrP Inhibitor 13 is an antiprion agent inhibiting protease-resistant prion protein (PrP-res) accumulation.

TCS PrP Inhibitor 13 is an antiprion agent inhibiting protease-resistant prion protein (PrP-res) accumulation.(In Vitro):In Schwannoma cells, administration of 0-500 μM TCS PrP Inhibitor 13 reduces levels of total ERK1/2, pAKT, total FAK, Cyclin D1, PrPC and increases expression of cleaved caspase-3 significantly. TCS PrP Inhibitor 13 also significantly reduces the number of proliferating, Ki67-positive cells and total cell number in Schwannoma cells.

TCS PrP Inhibitor 13 (0~500 μM; Schwannoma cells) significantly reduces levels of total ERK1/2, pAKT, total FAK, Cyclin D1, PrPC and significantly increases expression of cleaved caspase-3. TCS PrP Inhibitor 13 (Schwannoma cells) significantly reduces the number of proliferating, Ki67-positive cells and total cell number.

——

5-(4-Nitrophenyl)-2-Phenyl-4H-Pyrazol-3-One

Others

Other Targets

——

——

——

34320-83-7

281.271

C15H11N3O3

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (355.53 mM)

[O-][N+](=O)c1ccc(cc1)C1=NN(C(=O)C1)c1ccccc1

——

(-20℃)

With Ice Pack

≥ 2 years